Literature DB >> 2834514

Adenosine receptors activate adenylate cyclase and enhance secretion from bovine adrenal chromaffin cells in the presence of forskolin.

Y J Chern1, K T Kim, L L Slakey, E W Westhead.   

Abstract

Cells of the adrenal medulla release not only catecholamines but also high concentrations of neuropeptides and nucleotides. Chromaffin cells, like many neuronal cells, have a diversity of receptors: adrenergic receptors, peptide receptors, histamine receptors, and dopamine receptors. We recently reported that these cells have nucleotide receptors that can mediate inhibition of the secretory response. The present studies show that adenosine, in the presence of enabling concentrations of forskolin, can potently enhance response to nicotinic stimulation. Neither adenosine nor forskolin alone produces a significant effect. A marked rise in intracellular cyclic AMP (cAMP) concentration is associated with the enhancement of secretion caused by forskolin plus adenosine. A phosphodiesterase inhibitor, Ro 20-1724, used together with forskolin produces significant increases in both cellular cAMP content and catecholamine secretion. However, the adenosine agonist 5'-N-ethylcarboxyadenosine elevates cellular cAMP content in the presence of forskolin without having any positive effect on secretion. This finding suggests that the rise in cAMP level may not be the sole cause of the increase in secretion by adenosine.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2834514     DOI: 10.1111/j.1471-4159.1988.tb03034.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  10 in total

1.  Multiple actions of extracellular ATP on calcium currents in cultured bovine chromaffin cells.

Authors:  M Diverse-Pierluissi; K Dunlap; E W Westhead
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

2.  Three types of bovine chromaffin cell Ca2+ channels: facilitation increases the opening probability of a 27 pS channel.

Authors:  C R Artalejo; D J Mogul; R L Perlman; A P Fox
Journal:  J Physiol       Date:  1991-12       Impact factor: 5.182

3.  Cellular responses to Ca2+ from extracellular and intracellular sources are different as shown by simultaneous measurements of cytosolic Ca2+ and secretion from bovine chromaffin cells.

Authors:  K T Kim; E W Westhead
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

4.  ATP modulation of calcium channels in chromaffin cells.

Authors:  L Gandía; A G García; M Morad
Journal:  J Physiol       Date:  1993-10       Impact factor: 5.182

5.  GABAB receptors modulate catecholamine secretion in chromaffin cells by a mechanism involving cyclic AMP formation.

Authors:  M J Oset-Gasque; M Parramón; M P González
Journal:  Br J Pharmacol       Date:  1993-12       Impact factor: 8.739

6.  Cholinoceptor regulation of cyclic AMP levels in bovine adrenal medullary cells.

Authors:  K Anderson; P J Robinson; P D Marley
Journal:  Br J Pharmacol       Date:  1992-06       Impact factor: 8.739

7.  Effect of diadenosine polyphosphates on catecholamine secretion from isolated chromaffin cells.

Authors:  E Castro; M Torres; M T Miras-Portugal; M P Gonzalez
Journal:  Br J Pharmacol       Date:  1990-06       Impact factor: 8.739

8.  A reassessment of the modulatory role of cyclic AMP in catecholamine secretion by chromaffin cells.

Authors:  M Parramón; M P González; M J Oset-Gasque
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

9.  Cyclic AMP-induced depolarization measured by bis-oxonol fluorescence in bovine adrenal medullary chromaffin cells.

Authors:  N Minami; K Morita; T Suemitsu; T Miyasako; T Dohi
Journal:  J Neural Transm Gen Sect       Date:  1994

Review 10.  Pharmacological implications of the Ca(2+)/cAMP signaling interaction: from risk for antihypertensive therapy to potential beneficial for neurological and psychiatric disorders.

Authors:  Afonso Caricati-Neto; Antonio G García; Leandro Bueno Bergantin
Journal:  Pharmacol Res Perspect       Date:  2015-09-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.